HY001N for Patients With Autoimmune Hemolytic Anemia After Failure ≥3 Lines of Therapy.
Clinical trial NCT07748533 · RECRUITING
Trial details
- NCT number
- NCT07748533
- Sponsor
- Juventas Cell Therapy Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-02
- Primary completion
- 2028-09-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.